位置:首页 > 蛋白库 > HRH1_MOUSE
HRH1_MOUSE
ID   HRH1_MOUSE              Reviewed;         488 AA.
AC   P70174; Q91V75; Q91XN0; Q91XN1; Q91XN2; Q91XN3;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   09-MAY-2003, sequence version 2.
DT   03-AUG-2022, entry version 175.
DE   RecName: Full=Histamine H1 receptor;
DE            Short=H1R;
DE            Short=HH1R;
GN   Name=Hrh1; Synonyms=Bphs;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=129/Ola;
RX   PubMed=8812432; DOI=10.1006/geno.1996.0441;
RA   Inoue I., Taniuchi I., Kitamura D., Jenkins N.A., Gilbert D.J.,
RA   Copeland N.G., Watanabe T.;
RT   "Characteristics of the mouse genomic histamine H1 receptor gene.";
RL   Genomics 36:178-181(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE, AND VARIANTS LEU-263; MET-312 AND SER-330.
RC   STRAIN=129/SvJ, A/J, B10.S/DvTe, BALB/cByJ, BALB/cJ, C3H/HeJ, C57BL/6J,
RC   CBA/J, DBA/1, DBA/2J, FVB/NCr, NOD, SJL/J, and SWR; TISSUE=Spleen;
RX   PubMed=12142541; DOI=10.1126/science.1072810;
RA   Ma R.Z., Gao J., Meeker N.D., Fillmore P.D., Tung K.S.K., Watanabe T.,
RA   Zachary J.F., Offner H., Blankenhorn E.P., Teuscher C.;
RT   "Identification of Bphs, an autoimmune disease locus, as histamine receptor
RT   H1.";
RL   Science 297:620-623(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J;
RC   TISSUE=Adipose tissue, Cerebellum, Hypothalamus, and Mesonephros;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [4]
RP   FUNCTION.
RX   PubMed=8917588; DOI=10.1073/pnas.93.23.13316;
RA   Inoue I., Yanai K., Kitamura D., Taniuchi I., Kobayashi T., Niimura K.,
RA   Watanabe T., Watanabe T.;
RT   "Impaired locomotor activity and exploratory behavior in mice lacking
RT   histamine H1 receptors.";
RL   Proc. Natl. Acad. Sci. U.S.A. 93:13316-13320(1996).
RN   [5]
RP   FUNCTION.
RX   PubMed=12595443; DOI=10.1128/iai.71.3.1281-1287.2003;
RA   Gao J.F., Call S.B., Fillmore P.D., Watanabe T., Meeker N.D., Teuscher C.;
RT   "Analysis of the role of Bphs/Hrh1 in the genetic control of responsiveness
RT   to pertussis toxin.";
RL   Infect. Immun. 71:1281-1287(2003).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-344; SER-347; SER-381 AND
RP   SER-383, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
CC   -!- FUNCTION: In peripheral tissues, the H1 subclass of histamine receptors
CC       mediates the contraction of smooth muscles, increase in capillary
CC       permeability due to contraction of terminal venules, and catecholamine
CC       release from adrenal medulla, as well as mediating neurotransmission in
CC       the central nervous system. Involved in circadian rhythm of locomotor
CC       activity and exploratory behavior. Also involved in responsiveness to
CC       pertussis toxin through its control of susceptibility to histamine
CC       hypersensitivity and enhancement of antigen-specific delayed-type
CC       hypersensitivity responses. {ECO:0000269|PubMed:12595443,
CC       ECO:0000269|PubMed:8917588}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC   -!- PTM: Phosphorylation at sites in the second and third cytoplasmic loops
CC       independently contribute to agonist-induced receptor down-regulation.
CC       {ECO:0000250}.
CC   -!- POLYMORPHISM: Strains C3H/HeJ and CBA/J are resistant to vasoactive
CC       amine sensitization elicited by histamine (VAASH) which is induced by
CC       pertussis toxin. {ECO:0000269|PubMed:12142541}.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00521}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D50095; BAA08791.1; -; Genomic_DNA.
DR   EMBL; AF387890; AAK71654.1; -; mRNA.
DR   EMBL; AF387891; AAK71655.1; -; mRNA.
DR   EMBL; AF387892; AAK71656.1; -; mRNA.
DR   EMBL; AF387893; AAK71657.1; -; mRNA.
DR   EMBL; AF387894; AAK71658.1; -; mRNA.
DR   EMBL; AF387895; AAK71659.1; -; mRNA.
DR   EMBL; AF387896; AAK71660.1; -; mRNA.
DR   EMBL; AF388052; AAK66774.2; -; mRNA.
DR   EMBL; AF388053; AAK66775.1; -; mRNA.
DR   EMBL; AF388054; AAK66776.1; -; mRNA.
DR   EMBL; AF388055; AAK66777.1; -; mRNA.
DR   EMBL; AF388056; AAK66778.1; -; mRNA.
DR   EMBL; AF388057; AAK66779.1; -; mRNA.
DR   EMBL; AF388058; AAK66780.1; -; mRNA.
DR   EMBL; AK032763; BAC28011.1; -; mRNA.
DR   EMBL; AK038480; BAC30013.1; -; mRNA.
DR   EMBL; AK046607; BAC32805.1; -; mRNA.
DR   EMBL; AK047070; BAC32950.1; -; mRNA.
DR   CCDS; CCDS20435.1; -.
DR   RefSeq; NP_001239571.1; NM_001252642.2.
DR   RefSeq; NP_001239572.1; NM_001252643.2.
DR   RefSeq; NP_001304053.1; NM_001317124.1.
DR   RefSeq; NP_001304054.1; NM_001317125.1.
DR   RefSeq; NP_001304055.1; NM_001317126.1.
DR   RefSeq; NP_032311.2; NM_008285.4.
DR   AlphaFoldDB; P70174; -.
DR   SMR; P70174; -.
DR   STRING; 10090.ENSMUSP00000086383; -.
DR   BindingDB; P70174; -.
DR   ChEMBL; CHEMBL4322; -.
DR   DrugBank; DB11160; Phenyltoloxamine.
DR   DrugBank; DB00512; Vancomycin.
DR   GlyGen; P70174; 2 sites.
DR   iPTMnet; P70174; -.
DR   PhosphoSitePlus; P70174; -.
DR   jPOST; P70174; -.
DR   MaxQB; P70174; -.
DR   PaxDb; P70174; -.
DR   PRIDE; P70174; -.
DR   ProteomicsDB; 273382; -.
DR   Antibodypedia; 10679; 552 antibodies from 38 providers.
DR   DNASU; 15465; -.
DR   Ensembl; ENSMUST00000088987; ENSMUSP00000086383; ENSMUSG00000053004.
DR   Ensembl; ENSMUST00000160780; ENSMUSP00000124320; ENSMUSG00000053004.
DR   Ensembl; ENSMUST00000161220; ENSMUSP00000124037; ENSMUSG00000053004.
DR   Ensembl; ENSMUST00000161650; ENSMUSP00000124460; ENSMUSG00000053004.
DR   GeneID; 15465; -.
DR   KEGG; mmu:15465; -.
DR   UCSC; uc009dhw.1; mouse.
DR   CTD; 3269; -.
DR   MGI; MGI:107619; Hrh1.
DR   VEuPathDB; HostDB:ENSMUSG00000053004; -.
DR   eggNOG; KOG4220; Eukaryota.
DR   GeneTree; ENSGT00940000160690; -.
DR   HOGENOM; CLU_009579_11_2_1; -.
DR   InParanoid; P70174; -.
DR   OMA; YVAINQS; -.
DR   OrthoDB; 1245472at2759; -.
DR   PhylomeDB; P70174; -.
DR   TreeFam; TF333432; -.
DR   Reactome; R-MMU-390650; Histamine receptors.
DR   Reactome; R-MMU-416476; G alpha (q) signalling events.
DR   BioGRID-ORCS; 15465; 2 hits in 73 CRISPR screens.
DR   PRO; PR:P70174; -.
DR   Proteomes; UP000000589; Chromosome 6.
DR   RNAct; P70174; protein.
DR   Bgee; ENSMUSG00000053004; Expressed in subparaventricular zone and 76 other tissues.
DR   ExpressionAtlas; P70174; baseline and differential.
DR   Genevisible; P70174; MM.
DR   GO; GO:0005829; C:cytosol; ISO:MGI.
DR   GO; GO:0030425; C:dendrite; IBA:GO_Central.
DR   GO; GO:0005887; C:integral component of plasma membrane; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; ISO:MGI.
DR   GO; GO:0045202; C:synapse; IEA:GOC.
DR   GO; GO:0015085; F:calcium ion transmembrane transporter activity; ISO:MGI.
DR   GO; GO:0004993; F:G protein-coupled serotonin receptor activity; IBA:GO_Central.
DR   GO; GO:0051381; F:histamine binding; ISO:MGI.
DR   GO; GO:0004969; F:histamine receptor activity; ISS:UniProtKB.
DR   GO; GO:0030594; F:neurotransmitter receptor activity; IBA:GO_Central.
DR   GO; GO:0070509; P:calcium ion import; ISO:MGI.
DR   GO; GO:0071420; P:cellular response to histamine; ISS:UniProtKB.
DR   GO; GO:0007268; P:chemical synaptic transmission; ISO:MGI.
DR   GO; GO:0048245; P:eosinophil chemotaxis; IEA:InterPro.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0007187; P:G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; IBA:GO_Central.
DR   GO; GO:0071421; P:manganese ion transmembrane transport; ISO:MGI.
DR   GO; GO:0007613; P:memory; IMP:MGI.
DR   GO; GO:0010894; P:negative regulation of steroid biosynthetic process; ISO:MGI.
DR   GO; GO:0045429; P:positive regulation of nitric oxide biosynthetic process; ISO:MGI.
DR   GO; GO:0045907; P:positive regulation of vasoconstriction; ISO:MGI.
DR   GO; GO:0048167; P:regulation of synaptic plasticity; IMP:MGI.
DR   GO; GO:0043114; P:regulation of vascular permeability; IEA:InterPro.
DR   GO; GO:0048511; P:rhythmic process; IEA:UniProtKB-KW.
DR   GO; GO:0008542; P:visual learning; IMP:MGI.
DR   InterPro; IPR000276; GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_7TM.
DR   InterPro; IPR000921; Histamine_H1_rcpt.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   PRINTS; PR00530; HISTAMINEH1R.
DR   SMART; SM01381; 7TM_GPCR_Srsx; 1.
DR   PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   1: Evidence at protein level;
KW   Biological rhythms; Cell membrane; Disulfide bond;
KW   G-protein coupled receptor; Glycoprotein; Membrane; Phosphoprotein;
KW   Receptor; Reference proteome; Transducer; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN           1..488
FT                   /note="Histamine H1 receptor"
FT                   /id="PRO_0000069677"
FT   TOPO_DOM        1..29
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        30..52
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        53..62
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        63..83
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        84..101
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        102..123
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        124..143
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        144..164
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        165..189
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        190..210
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        211..417
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        418..439
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        440..451
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        452..471
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        472..488
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   REGION          107..112
FT                   /note="Important for agonist binding"
FT                   /evidence="ECO:0000250"
FT   REGION          245..337
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          425..429
FT                   /note="Important for agonist binding"
FT                   /evidence="ECO:0000250"
FT   COMPBIAS        245..260
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        269..293
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        321..337
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         140
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P35367"
FT   MOD_RES         142
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P35367"
FT   MOD_RES         230
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P35367"
FT   MOD_RES         344
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         347
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         381
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         383
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         397
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P35367"
FT   MOD_RES         399
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P35367"
FT   CARBOHYD        5
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        18
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        100..180
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00521"
FT   DISULFID        442..445
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00521"
FT   VARIANT         263
FT                   /note="P -> L (in strain: C3H/HeJ and CBA/J)"
FT                   /evidence="ECO:0000269|PubMed:12142541"
FT   VARIANT         312
FT                   /note="V -> M (in strain: C3H/HeJ and CBA/J)"
FT                   /evidence="ECO:0000269|PubMed:12142541"
FT   VARIANT         330
FT                   /note="P -> S (in strain: C3H/HeJ and CBA/J)"
FT                   /evidence="ECO:0000269|PubMed:12142541"
FT   CONFLICT        2
FT                   /note="S -> R (in Ref. 1; BAA08791)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        47
FT                   /note="L -> G (in Ref. 1; BAA08791)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        79
FT                   /note="V -> I (in Ref. 1; BAA08791)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        215..216
FT                   /note="KA -> NG (in Ref. 1; BAA08791)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        224
FT                   /note="R -> P (in Ref. 1; BAA08791)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        242
FT                   /note="E -> D (in Ref. 2; AAK66778)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        244
FT                   /note="A -> S (in Ref. 1; BAA08791)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        261
FT                   /note="K -> T (in Ref. 1; BAA08791)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        278
FT                   /note="E -> A (in Ref. 1; BAA08791)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        379
FT                   /note="S -> R (in Ref. 1; BAA08791)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   488 AA;  55682 MW;  82612DF712998B41 CRC64;
     MSLPNTSSAS EDKMCEGNRT AMASPQLLPL VVVLSSISLV TVGLNLLVLY AVRSERKLHT
     VGNLYIVSLS VADLIVGAVV MPMNILYLIM TKWSLGRPLC LFWLSMDYVA STASIFSVFI
     LCIDRYRSVQ QPLRYLRYRT KTRASATILG AWFLSFLWVI PILGWHHFTP LAPELREDKC
     ETDFYNVTWF KIMTAIINFY LPTLLMLWFY VKIYKAVRRH CQHRQLTNGS LPTFLEIKLR
     SEDAKEGAKK PGKESPWGVQ KRPSRDPTGG LDQKSTSEDP KVTSPTVFSQ EGERETVTRP
     CFRLDVMQTQ PVPEGDARGS KANDQTLSQP KMDEQSLSTC RRISETSEDQ TLVDRQSFSR
     TTDSDTSIEP GLGKVKARSR SNSGLDYIKV TWKRLRSHSR QYVSGLHLNR ERKAAKQLGC
     IMAAFILCWI PYFIFFMVIA FCNSCCSEPV HMFTIWLGYI NSTLNPLIYP LCNENFKKTF
     KKILHIRS
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024